From taste hedonics to motivational drive: central μ-opioid receptors and binge-eating behaviour
Open Access
- 12 May 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 12 (7), 995-1008
- https://doi.org/10.1017/s146114570900039x
Abstract
Endogenous opioids and µ-opioid receptors (MORs) have long been implicated in the mechanism of appetite control and, in particular, hedonic processes associated with food evaluation, consumption and orosensory reward processes. In animal models of binge eating, selective MOR antagonists suppress food consumption. In humans, non-selective opioid receptor antagonists reduce hedonic taste preferences and food intake, particularly for palatable foods, and cause short-term weight loss. These effects have been linked to direct stimulation of MORs and modulation of dopamine release within the reward circuitry including the nucleus accumbens. These findings suggest that reduction of MOR-mediated hedonic and motivation processes driving consumption of highly palatable foods may be a promising therapeutic approach and provide a strong rationale for developing safer and more selective MOR antagonists or inverse agonists for disorders of ‘appetitive motivation’ including obesity and binge-eating disorder.Keywords
This publication has 100 references indexed in Scilit:
- Prevalence and correlates of binge eating disorder in a community sampleComprehensive Psychiatry, 2007
- The Prevalence and Correlates of Eating Disorders in the National Comorbidity Survey ReplicationBiological Psychiatry, 2007
- Differential involvement of endogenous opioids in sucrose consumption and food reinforcementPharmacology Biochemistry and Behavior, 2006
- The role of palatable food and hunger as trigger factors in an animal model of stress induced binge eatingInternational Journal of Eating Disorders, 2003
- A double-blind, placebo-controlled trial of fluvoxamine in binge eating disorder: a high placebo responseArchives of Women's Mental Health, 2003
- Recent advances in molecular recognition and signal transduction of active peptides: Receptors for opioid peptidesCellular and Molecular Neurobiology, 1995
- Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in ratsBrain Research, 1995
- Naloxone suppresses intake of highly preferred saccharin solutions in food deprived and sated ratsLife Sciences, 1983
- Changes of beta-endorphin and somatostatin concentrations in different hypothalamic areas of female rats after chronic starvationLife Sciences, 1983
- Suppression of appetitive behavior in the rat by naloxone: Lack of effect of prior morphine dependenceLife Sciences, 1979